Has Aisha Malik, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,134 in general payments to Aisha Malik, MD across 249 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Aisha Malik, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Aisha Malik, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Aisha Malik, MD

Neurology · Bradenton, FLNPI 1235389537

Payments from drug & device makers

$5,134in general payments, 2019–2025

Across 249 payments — averaging $20.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

MDD US Operations, LLC$727
UCB, Inc.$400
AbbVie$397
Teva Pharmaceuticals USA, Inc.$296
AstraZeneca$280
Pfizer$266
plus $3K from 37 others

What the payments were for

Speaking & faculty fees$661%
Food & beverage$5,06899%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
MDD US Operations, LLC	41	$727
UCB, Inc.	14	$400
AbbVie(2 entities)	19	$397
Teva Pharmaceuticals USA, Inc.	14	$296
AstraZeneca	12	$280
Pfizer	16	$266
Acadia Pharmaceuticals Inc	9	$206
Biogen	11	$197
Neurocrine Biosciences, Inc.	9	$196
Takeda Pharmaceuticals U.S.A., Inc.	7	$173
EMD Serono, Inc.	3	$151
Supernus Pharmaceuticals, Inc.	9	$151
Lilly USA, LLC	6	$139
CSL Behring	5	$116
GE HealthCare	7	$97
Argenx US, Inc.	5	$93
Sumitomo Pharma America, Inc.	4	$91
Novartis	6	$86
Eisai Inc.	3	$72
Bristol Myers Squibb	3	$72
Acorda Therapeutics, Inc	3	$66
Avanir Pharmaceuticals, Inc.	4	$64
Avadel CNS Pharmaceuticals, LLC	2	$59
SK Life Science, Inc.	2	$58
Tanabe Pharma America, Inc.	3	$56
Sanofi	2	$53
Impel Pharmaceuticals LLC	3	$53
Sunovion Pharmaceuticals Inc.	3	$52
Amneal Pharmaceuticals LLC	2	$45
Genentech USA, Inc.	2	$44
Mallinckrodt Hospital Products Inc.	3	$43
Amgen(2 entities)	2	$40
Grifols USA, LLC	2	$39
Axsome Therapeutics, Inc.	2	$35
Lundbeck LLC	2	$31
Johnson & Johnson(2 entities)	2	$31
C2n Diagnostics, LLC	1	$29
Otsuka America Pharmaceutical, Inc.	1	$28
Neurelis, Inc.	1	$26
Abbott	1	$25
Adamas Pharmaceuticals, Inc.	1	$25
Merz Pharmaceuticals, LLC	1	$20
Portola Pharmaceuticals, LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GOCOVRI$290

How this compares

$5,134 in reported general payments places this provider in the 55th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Medicare billing

Part B allowed, 2024

$44,459

Medicare patients

171

Services billed

405

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Rasagiline Mesylate	26	$7,521
Donepezil Hcl	75	$2,564
Carbidopa-LevodopaCarbidopa/Levodopa	57	$1,114
Gabapentin	61	$940
Primidone	39	$724
Baclofen	25	$668
Memantine Hcl	35	$614
Galantamine ErGalantamine Hbr	11	$490
Escitalopram Oxalate	38	$345
Propranolol Hcl	17	$313
Amitriptyline Hcl	36	$278
Pramipexole DihydrochloridePramipexole Di-Hcl	11	$277
Ropinirole Hcl	21	$274
Clonazepam	12	$151
Quetiapine Fumarate	16	$77

Paid to pharmacies, not to this prescriber.

Other neurology in Bradenton

Sanjay YathirajBradenton$2.4M
Mark GoldsteinAtlantis$36.1M
Derrick RobertsonTampa$27.6M
Beth SafirsteinHallandale Beach$25.7M
Michael PfefferMiami$24.5M
Mark BrodyDelray Beach$20.5M
Paayal PatelWest Palm Beach$17.3M
Wendy BondFort Myers$14.7M
William HoneycuttMaitland$14.1M
Julie SchwartzbardAventura$13.6M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →